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Background: Antihypertensive medications have variable effects on the duration of the QT interval. This
study aims to demonstrate the subclinical ventricular conduction defect in treating hypertensive
patients taking in consideration the status of the blood pressure control with the antihypertensive
agents.
Methods: This cross-section study was performed at the Departments of Physiology and Pharmacology,
College of Medicine, Al-Mustansiriya University, Baghdad, Iraq. A total number of 97 hypertensive
patients (30 males and 67 females) were eligible to enroll in the study. The patients were grouped into
controlled hypertension (Group I) and uncontrolled hypertension (Group II). Each participant is
subjected to the electrocardiograph (ECG) investigation. A QT nomogram plot used to identify the
patients who are vulnerable or at risk of developing cardiac arrhythmias.
Results: There were no signiﬁcant differences in the values of the electrocardiogram determinants
between Group I and Group II. Abnormal prolonged QTcB interval observed in 18 out of 80 (22.5%)
patients of Group II compared with 4 out of 17. The JT index value of 112 was observed in 20 out of 80
(25%) patients of Group II compared with 6 out of 17 (35.3%) patients of Group I. A signiﬁcant correlation
between the QTcB duration with JT index observed in both Groups I and II.
Conclusion: Patients with hypertension have variability in ventricular repolarization (QTcB and JT)
irrespective of their blood pressure control putting them at higher risk of cardiac arrhythmias.
 2016 Published by Elsevier B.V. on behalf of Cardiological Society of India. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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The duration of the QT interval is one of the ventricular
repolarization markers that can predict malignant arrhythmias in
several diseases, including hypertension.1 The QT interval is
considered as one of the predictors of the risk of both coronary
events and cardiovascular death in patients with hypertension.2 In
patients with uncomplicated hypertension, a prolonged corrected
QT (QTc) interval is accompanied with a twofold increase in the
risk of cardiac events after adjusting the other risk factors.3 In
elderly subjects the duration of the QT interval is considered as a
prognostic marker as Dimopoulos et al. found a high blood
pressure (systolic and diastolic), and cardiac arrhythmias are
associated with a higher value of the QTc dispersion.4 Prolonged
ventricular repolarization found to be a risk factor of cardiac
morbidity and mortality in patients with resistant hypertension* Corresponding author at: Section 839, Avenue 42, House No. 14, Baghdad, Iraq.
E-mail address: alnimermarwan@ymail.com (Marwan S.M. Al-Nimer).
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induced hypertension, the duration of the QT interval found to be
within the normal range of the healthy women.5 In hypertension
associated with obesity, the duration of QTc interval is prolonged
and tended to be decreased after blood pressure control and weight
loss.6 Antihypertensive drugs (angiotensin converting enzyme
inhibitors and angiotensin receptor blockers) reduced the duration
of QT interval due to their effects on the left ventricular mass which
increases in hypertension.7–9 Beta-adrenoceptor blockers may also
reduce the duration of the QT interval in a dose-dependent manner
without having any effect on the blood pressure10,11 while calcium
channel blockers (dihydropyridine) do not exert a beneﬁcial effect
on QT interval.12 High ceiling diuretics and thiazides may prolong
QT interval due to electrolyte disturbances13 while potassium
sparing diuretics shortened the QTc interval.14 The duration of JT
interval is also a marker of ventricular repolarization and it is of
more beneﬁt than QT interval because the Bazett’s formula of QTc
exaggerates heart rate-dependency of ventricular repolarization
intervals.15 Li et al. demonstrated the association between
metabolic syndrome and prolonged QT and JT intervals and thesebclinical ventricular repolarization abnormality in uncontrolled
6), http://dx.doi.org/10.1016/j.ihj.2016.07.021
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Table 1
Cut-off value of QTcB according to age and gender.
Category Children and adolescent
<18 years
Adult male Adult female
Normal <0.44 s <0.43 s <0.45 s
Borderline 0.44–0.46 s 0.43–0.45 s 0.45–0.47 s
Prolonged >0.46 s >0.45 s >0.47 s
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derangement.16 Hypertensive patients treated with different
antihypertensive drugs may have abnormal cardiac electrophysi-
ology, in addition, the status of blood pressure control may also
inﬂuence the duration of ventricular repolarization. Therefore, this
study aims to demonstrate the subclinical ventricular conduction
defects in treating hypertensive patients taking in consideration
the status of the blood pressure control.
2. Materials and methods
This cross-section study was performed at the Departments of
Physiology and Pharmacology, College of Medicine, Al-Mustansir-
iya University, Baghdad, Iraq in accordance with the Declaration of
Helsinki. The study protocol was approved by the Institutional
Scientiﬁc Committee. The study included hypertensive patients
who were followed up with a diagnosis of essential hypertension at
the private clinics between January 1, 2014 and January 30,
2015. All patients provided informed consent to participate in the
study. The criteria of inclusion were essential hypertension treated
with antihypertensive drugs. The criteria of exclusion included
secondary hypertension, diabetes mellitus, pregnancy, renal and
hepatic failure. From each patient, the subjective data related to
the current medical and the other associated illnesses were
obtained. Each patient was examined clinically and the blood
pressure was measured on sitting position. The mean of three
readings of the blood pressure was taken. The mean arterial blood
pressure was determined using the following equation: Mean
arterial blood pressure (mmHg) = Diastolic + (1/3) pulse pressure.
The pulse pressure is equal to systolic minus diastolic blood
pressure.
Controlled hypertension was diagnosed as systolic and diastolic
blood pressure <140 mmHg and <90 mmHg, respectively while a
systolic and/or diastolic blood pressure 140 mmHg and/or
90 mmHg was diagnosed uncontrolled hypertension at the time
of the current use of antihypertensive drugs.
Each participant is subjected to the electrocardiograph (ECG)
investigation. Speciﬁcations of the ECG machine are: 12 standard
leads, the sensitivity is 10 mm/mV, the record speed is 25 mm/s.
The ECG records of patients who were in sinus rhythm are
obtained. All ECG waveforms were veriﬁed by visual inspection.17
The ECG record strips were scanned and the scanned picture was
magniﬁed by PC windows photo-viewer to zoom. From each ECG
record strips, the following data were obtained: heart rate (beats/
min); R-R interval (s); P-R interval (s); QRS wave duration (s); QTm
(QT measured) interval (s); QTc (QT corrected) interval (s); JTm (JT
measured) interval (s); JTc (JT corrected) interval (s) and JT index.
QTc (QT corrected) interval (s): it is calculated by using the
following formulae18:
Bazett formulaðQTCBÞ ¼ QTm=
ﬃﬃﬃﬃﬃﬃ
RR
p
The cutoff point of QTcB value is used according to Goldberg
et al.19 with a modiﬁcation of children and adolescent age that
instead of <15 years, 18 year old is considered (Table 1).
The JTm (s) was calculated by subtracting QRS complex
duration from QT interval and the corrected (JTc) was calculated
by subtracting of the duration of QRS complex from QTcB. The JT
index = JTm (heart rate + 100)/518, and a cutoff value of 112
indicated a prolonged duration of ventricular repolarization in
ventricular conduction defect.20 A QT nomogram plot that
developed by Chan et al., used to identify the patients who are
vulnerable or at risk of developing cardiac arrhythmias.21 The QT-
nomogram plot represented a plot of heart rate against the QT
interval and any point out of the curve indicated that the patient is
vulnerable to cardiac arrhythmias.Please cite this article in press as: Al-Nimer MSM, Hussein II. Su
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67 females) were enrolled in this study. Seventeen of them have a
blood pressure of less than 140 (systolic) and less than 90
(diastolic), and this group represented as controlled hypertension
and assigned Group I. Eight patients have either high systolic, or
diastolic or both and represented as uncontrolled hypertension
and assigned Group II.
Six patients have a systolic blood pressure 140 mmHg and a
diastolic blood pressure <90 (Group IIA), 12 patients have a
diastolic blood pressure 90 mmHg and a systolic blood pressure
<140 (Group IIB), and 62 patients have a systolic and diastolic
blood pressure 140 and 90 mmHg respectively (Group IIC).
2.1. Statistical analysis
The statistical analysis was performed by using SPSS v.20.0 for
Windows (IBM Corp., Armonk, NY, USA). The results are expressed
as a number and mean  SD. The difference between percentage
tests was used to compare categorical variables. The differences in
means were analyzed by using the two tailed unpaired t-test and a
simple correlation test was used to determine the relationship
between hematological indices and the variables related to the mean
blood pressure and the other metabolic derangement determinants.
The level of statistical signiﬁcance was set at p  0.05.
3. Results
Table 1 showed that there are insigniﬁcant variation in age and
duration of hypertension between the groups. The habit of current
smoking is observed in a signiﬁcant high percent in Group II
compared with Group I. Previous history of stroke and ischemic
heart disease observed in a signiﬁcant high frequency in Group II
compared with Group I (Table 2). Variability in the prescription of
antihypertensive drugs observed in Group II compared with group
I. At the time of entry, signiﬁcant high systolic, diastolic, and both
systolic and diastolic blood pressure observed in 6, 12, and
62 patients, respectively (Group II) compared with 17 out
97 patients were under control blood pressure (Table 3) Accord-
ingly the pulse pressure and the mean arterial blood pressures
were signiﬁcantly differed from the corresponding values of Group
I. (Table 3). There were no signiﬁcant differences in the values of
the electrocardiogram determinants between controlled hyper-
tension (Group I) and uncontrolled hypertension (Group II)
(Table 4). Abnormal prolonged QTcB interval observed in 18 out
of 80 (22.5%) patients of Group II compared with 4 out of 17 (23.5%)
patients of Group I, the difference did not reach a signiﬁcant level.
The JT index value of 112 was observed in 20 out of 80 (25%)
patients of Group II compared with 6 out of 17 (35.3%) patients of
Group I, the difference did not reach a signiﬁcant level (Table 4).
Fig. 1 shows that 8 patients (1 belonged to Group I and 7 belonged
to Group II) were vulnerable to cardiac arrhythmias, the difference
did not reach to the signiﬁcant level (5.9% versus 8.8% respective-
ly). Fig. 2 shows signiﬁcant correlations between the QTcB interval
with JT index in both Groups I and II. The coefﬁcient factors were
0.841 and 0.742 for Groups I and II respectively. The frequency of
borderline-pathological prolonged QTcB interval observed in
13 out of 43 patients using antihypertensive drugs in term ofbclinical ventricular repolarization abnormality in uncontrolled
6), http://dx.doi.org/10.1016/j.ihj.2016.07.021
Table 2
Characteristics of the study.
Characteristics Controlled
hypertension
Uncontrolled hypertension
Group I
(n = 17)
Group IIA
(n = 6)
Group IIB
(n = 12)
Group IIC
(n = 62)
Gender (M:F) 4:13 1:5 3:9 22:40
Age (year) 60.3  6.4 62.8  9.5 59.4  4.1 65.8  8.4
Duration of
hypertension (year)
10.8  4.3 13.0  5.7 12.0  3.9 15.1  5.1
Current smoking 4 1 5 39
Previous history
Hypertensive crisis 0 0 0 0
Transient ischemic
attack
0 0 0 6
Migraine 1 0 0 2
Stroke 2 1 3 33**
Ischemic heart disease 4 2 4 25
Current medications
Lipid lowering agents 13 6 7 43
ACEI 6 2 1 19
ARBs 5 3 5 27
Beta-blockers 6 3 6 28
Alpha-blockers 4 0 3 7
Thiazides 4 0 2 10
The results are expressed as number and mean  SD.
** p = 0.008.
Table 3
Blood pressure measurements.
Blood pressure
(mmHg)
Group I
(n = 17)
Group IIA
(n = 6)
Group IIB
(n = 12)
Group IIC
(n = 62)
Systolic 125.3  8.6 150.8  15.0* 127.1  6.6 159.9  14.7**
Diastolic 82.1  2.5 80.8  2.0 93.3  4.9** 100.8  8.7**
Pulse 43.2  8.8 70.0  15.5* 33.8  8.0* 59.1  14.5**
Mean arterial 96.5  3.4 104.1  4.9* 104.6  4.0** 120.5  8.7**
The results are expressed as mean  SD.
* p < 0.01 compared with corresponding value of Group I.
** p < 0.001 compared with corresponding value of Group I.
Fig. 1. QT nomogram shows the patients who are vulnerable to cardiac arrhythmias
represented by dots above the curve line of nomogram.
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these medications, the difference did not reach signiﬁcant levels
(30.2% versus 20% respectively) (Table 5).
4. Discussion
The results of this study demonstrate prolonged QTcB interval
and a higher JT index in patients with hypertension, whether
controlled or uncontrolled and drugs that produce conductionTable 4
Analysis of electrocardiogram data.
Electrocardiogram parameters Controlled hypertension
(n = 17)
Group I
(n = 17)
Heart rate 79.2  16.4 
P-R interval (s) 0.152  0.060 
R-R interval (s) 0.762  0.152 
QRS complex duration (s) 0.065  0.023 
QTc m (s) 0.365  0.052 
QTCB (s) 0.423  0.066 
Normal range 12 
Borderline range 1 
Abnormal range 4 
JTm (s) 0.300  0.045 
JTc (s) 0.368  0.065 
JT index 103.62  16.93 
JT index 112 (no.) 6 
The results are expressed as mean  SD. Non-signiﬁcant difference between Group I and
Please cite this article in press as: Al-Nimer MSM, Hussein II. Su
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study point out that approximately a quarter of patients are at risk
of cardiac arrhythmias as a result of a defect in ventricular
repolarization. Measurement of QTcB and JT index considered as a
good marker of assessment ventricular repolarization and varia-
tion of the ventricular repolarization may predispose to the
malignant arrhythmias.22 There is evidence that patients with QTc
duration of 530 ms are at risk of cardiac arrest and sudden cardiac
death.23 Therefore, we can expect that a number of our patients are
at risk of sudden cardiac death because of cardiac arrhythmias. It is
important to mention here that genetic factor is the cause of the
prolonged of the QTcB period in some patients, but it is unlikely to
be the cause of about 25% of our patients.24–26 The cause of
prolonged QTcB interval in this study is acquired due to
hypertension. Hypertension per se has an increased risk of
arrhythmias due to an increase of dispersion of ventricular
repolarization that resulted from left ventricular hypertrophy.27–
29 Previous studies reported that prolonged QTcB period is
demonstrated in resistant hypertension and related to the systolic
blood pressure, obesity and left ventricular mass.30,31 In this study
the prolonged QTcB period is demonstrated in both controlled and
uncontrolled hypertension. Acute myocardial ischemia that
follows hypertension may be the cause of prolonged QTcB. In this
study signiﬁcant high number of uncontrolled hypertension had a
history of chronic myocardial ischemia and it may be not a sole
cause because there is non-signiﬁcant difference in the electro-
cardiogram determinants between Group I and II was observed. A
considerable number of patients who have a JT index 112 areUncontrolled hypertension
(n = 80)
Group IIA
(n = 6)
Group IIB
(n = 12)
Group IIC
(n = 62)
90.3  11.0 75.4  13.2 84.7  17.7
0.163  0.050 0.147  0.055 0.150  0.035
0.650  0.096 0.788  0.157 0.750  0.263
0.068  0.033 0.080  0.036 0.070  0.025
0.370  0.045 0.362  0.065 0.361  0.066
0.459  0.041 0.410  0.058 0.424  0.064
2 9 43
2 1 5 (NS)
2 2 14 (NS)
0.302  0.029 0.282  0.043 0.290  0.065
0.391  0.027 0.330  0.049 0.354  0.065
110.4  6.4 94.74  11.54 102.7  19.55
2 1 17 (NS)
 Group IIA, IIB, and IIC.
bclinical ventricular repolarization abnormality in uncontrolled
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Table 5
Distribution of patients with borderline-pathological prolonged QTcB interval in
respect of using beta-adrenoceptor blockers.
Determinant Group I
(n = 17)
Group II
(n = 80)
Using
beta-blockers
(n = 6)
Not used
(n = 11)
Using
beta-blockers
(n = 37)
Not used
(n = 43)
QTcB
Borderline 1 0 3 5
Pathological
(prolonged)
0 4 12 6
JTI 112 2 4 11 7
The results are expressed as absolute number.
Fig. 2. Signiﬁcant correlations between QTCB interval and JT index in patients with
controlled (Group I) and uncontrolled (Group II) hypertension.
M.S.M. Al-Nimer, I.I. Hussein / Indian Heart Journal xxx (2016) xxx–xxx4
G Model
IHJ-1025; No. of Pages 5reported in this study which indicated that those patients are at
risk of sudden death. Zulqarnain et al. (2015) reported that
prolonged JT is a predictor of mortality in a population using
multivariate-adjusted Cox regression models.32 Panikkath et al.
found that the prolonged QT period is the only electrocardiograph
interval irrespective of JT interval was signiﬁcantly associated with
sudden cardiac death.33 This study demonstrates the signiﬁcant
correlation between QTCB and JT index in both controlled and
uncontrolled hypertension indicated that the utility of JT index can
be applied to detect the patients who are at risk of malignant
arrhythmias. One group of the antihypertensive drugs that used in
this study is beta-adrenoceptor blockers, which do not induce
signiﬁcant abnormality in electrocardiograph records compared
with those without using beta-adrenoceptor blockers. Beta-
adrenoceptor blockers in toxic dose, interfere with cardiac
conduction system while in therapeutic dose have no effect on
the electrocardiograph intervals.
4.1. Limitations
One of the limitations of this study is the determination of
electrocardiograph intervals in newly cases of hypertension before
the administration of antihypertensive drugs. Small sample size of
isolated hypertension is another limitation of the study.
5. Conclusion
We conclude that treated patients with hypertension presented
with controlled or uncontrolled high blood pressure are at risk of
cardiac arrhythmias due to the variability in the ventricular
repolarization by the evidence of prolonged QTcB and JT index.Please cite this article in press as: Al-Nimer MSM, Hussein II. Su
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